BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 29296152)

  • 1. The status of hepatitis B control in the African region.
    Breakwell L; Tevi-Benissan C; Childs L; Mihigo R; Tohme R
    Pan Afr Med J; 2017; 27(Suppl 3):17. PubMed ID: 29296152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress Toward Hepatitis B Control - South-East Asia Region, 2016-2019.
    Sandhu HS; Roesel S; Sharifuzzaman M; Chunsuttiwat S; Tohme RA
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(30):988-992. PubMed ID: 32730237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - World Health Organization African Region, 2016-2021.
    Kabore HJ; Li X; Alleman MM; Manzengo CM; Mumba M; Biey J; Paluku G; Bwaka AM; Impouma B; Tohme RA
    MMWR Morb Mortal Wkly Rep; 2023 Jul; 72(29):782-787. PubMed ID: 37471264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015.
    Childs L; Roesel S; Tohme RA
    Vaccine; 2018 Jan; 36(1):6-14. PubMed ID: 29174317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017.
    Woodring J; Pastore R; Brink A; Ishikawa N; Takashima Y; Tohme RA
    MMWR Morb Mortal Wkly Rep; 2019 Mar; 68(8):195-200. PubMed ID: 30817746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress Toward the Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Worldwide, 2016-2021.
    Khetsuriani N; Lesi O; Desai S; Armstrong PA; Tohme RA
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(30):958-963. PubMed ID: 35900928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of early horizontal transmission of hepatitis B virus in children of uninfected mothers in sub-Saharan Africa: a systematic review and meta-analysis.
    Ansari A; Vincent JP; Moorhouse L; Shimakawa Y; Nayagam S
    Lancet Glob Health; 2023 May; 11(5):e715-e728. PubMed ID: 37061310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress Toward Hepatitis B Control - World Health Organization European Region, 2016-2019.
    Khetsuriani N; Mosina L; Van Damme P; Mozalevskis A; Datta S; Tohme RA
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(30):1029-1035. PubMed ID: 34324482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Countries' interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions.
    Petit D; Tevi-Benissan C; Woodring J; Hennessey K; Kahn AL
    Vaccine; 2017 Dec; 35(49 Pt B):6866-6871. PubMed ID: 29132994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018.
    Minta AA; Silva MWT; Shrestha A; de Quiroz-Castro M; Tohme RA; Quimson ME; Jiz MA; Woodring J
    Vaccine; 2021 Apr; 39(14):1982-1989. PubMed ID: 33712351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Hepatitis B Birth-Dose Vaccination in São Tomé and Príncipe: A Program Assessment and Cost-Effectiveness Study.
    Hagan JE; Carvalho E; Souza V; Queresma Dos Anjos M; Abimbola TO; Pallas SW; Tevi Benissan MC; Shendale S; Hennessey K; Patel MK
    Am J Trop Med Hyg; 2019 Oct; 101(4):891-898. PubMed ID: 31392947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the impact of the routine childhood hepatitis B immunization program and the need for hepatitis B vaccine birth dose in Sierra Leone, 2018.
    Breakwell L; Marke D; Kaiser R; Tejada-Strop A; Pauly MD; Jabbi S; Yambasu S; Kabore HJ; Stewart B; Sesay T; Samba TT; Hayden T; Kamili S; Jambai A; Drobeniuc J; Singh T; Tohme RA; Wasley A
    Vaccine; 2022 Apr; 40(19):2741-2748. PubMed ID: 35361502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
    Ork V; Woodring J; Shafiqul Hossain M; Wasley A; Nagashima S; Yamamoto C; Chuon C; Sugiyama A; Ohisa M; Akita T; Ko K; Mao B; Tanaka J
    Vaccine; 2019 Aug; 37(35):5059-5066. PubMed ID: 31285088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual risk of mother-to-child transmission of HBV despite timely Hepatitis B vaccination: a major challenge to eliminate hepatitis B infection in Cambodia.
    E B; Ko K; Kim R; Nagashima S; Ouoba S; Hussain MRA; Sato T; Chuon C; Abe K; Sugiyama A; Takahashi K; Akita T; Tung R; Ork V; Hossain MS; Saphonn V; Tanaka J
    BMC Infect Dis; 2023 Apr; 23(1):261. PubMed ID: 37101167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study.
    Nayagam S; de Villiers MJ; Shimakawa Y; Lemoine M; Thursz MR; Walsh N; Hallett TB
    Lancet Gastroenterol Hepatol; 2023 Jul; 8(7):635-645. PubMed ID: 37150181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of Mother-to-Child Transmission of Hepatitis B Virus in Gulf Cooperation Council Countries: Current Status and Future Prospects.
    Al Awaidy S; Tohme RA; Al Romaihi HE; Ezzikouri S; Mahomed O
    Am J Trop Med Hyg; 2024 Jan; 110(1):32-35. PubMed ID: 38081049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia.
    Mao B; Patel MK; Hennessey K; Duncan RJ; Wannemuehler K; Soeung SC
    Vaccine; 2013 Sep; 31(40):4459-64. PubMed ID: 23684825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NéoVac Study).
    Gosset A; Diallo MY; Betsem E; Schaeffer L; Meda N; Vray M; Sombie R; Shimakawa Y; Boyer S
    Vaccine; 2021 Jul; 39(33):4659-4670. PubMed ID: 34238606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B vaccine birth dose coverage among hepatitis B-exposed and hepatitis B-unexposed infants: evidence from the Healthy Beginning Initiative program in Benue State, Nigeria.
    Olakunde BO; Itanyi IU; Onyeka TC; Paintsil E; Torpey K; Lasebikan N; Chigbu CO; Ezeanolue EE
    Pan Afr Med J; 2024; 47():67. PubMed ID: 38681098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.